Literature DB >> 32989594

JAK Inhibition in a Patient with X-Linked Reticulate Pigmentary Disorder.

Corinne Légeret1, Benedikt J Meyer2, Annette Rovina2, Nikolaus Deigendesch3, Christoph T Berger4, Thomas Daikeler5, Ingmar Heijnen6, Ezra Burstein7, Henrik Köhler1, Mike Recher8.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32989594      PMCID: PMC7846528          DOI: 10.1007/s10875-020-00867-7

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  7 in total

Review 1.  X-linked reticulate pigmentary disorder with systemic manifestations: a new family and review of the literature.

Authors:  Lidia Pezzani; Michela Brena; Michele Callea; Marina Colombi; Gianluca Tadini
Journal:  Am J Med Genet A       Date:  2013-04-23       Impact factor: 2.802

2.  Cryptogenic multifocal ulcerous stenosing enteritis (CMUSE) in a man with a diagnosis of X-linked reticulate pigmentary disorder (PDR).

Authors:  Guadalupe Fraile; Francesca Norman; Ma Eugenia Reguero; Vicente Defargues; Clara Redondo
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

3.  DNA polymerase-α regulates the activation of type I interferons through cytosolic RNA:DNA synthesis.

Authors:  Petro Starokadomskyy; Terry Gemelli; Jonathan J Rios; Chao Xing; Richard C Wang; Haiying Li; Vladislav Pokatayev; Igor Dozmorov; Shaheen Khan; Naoteru Miyata; Guadalupe Fraile; Prithvi Raj; Zhe Xu; Zigang Xu; Lin Ma; Zhimiao Lin; Huijun Wang; Yong Yang; Dan Ben-Amitai; Naama Orenstein; Huda Mussaffi; Eulalia Baselga; Gianluca Tadini; Eyal Grunebaum; Adrijan Sarajlija; Konrad Krzewski; Edward K Wakeland; Nan Yan; Maria Teresa de la Morena; Andrew R Zinn; Ezra Burstein
Journal:  Nat Immunol       Date:  2016-03-28       Impact factor: 25.606

4.  Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.

Authors:  Ann Elisabet Østvik; Tarjei Dahl Svendsen; Atle van Beelen Granlund; Berit Doseth; Helene Kolstad Skovdahl; Ingunn Bakke; Silje Thorsvik; Wahida Afroz; Gunnar Andreas Walaas; Tom Eirik Mollnes; Björn Inge Gustafsson; Arne Kristian Sandvik; Torunn Bruland
Journal:  J Crohns Colitis       Date:  2020-07-30       Impact factor: 9.071

5.  Evidence of innate lymphoid cell redundancy in humans.

Authors:  Frédéric Vély; Vincent Barlogis; Blandine Vallentin; Bénédicte Neven; Christelle Piperoglou; Mikael Ebbo; Thibaut Perchet; Maxime Petit; Nadia Yessaad; Fabien Touzot; Julie Bruneau; Nizar Mahlaoui; Nicolas Zucchini; Catherine Farnarier; Gérard Michel; Despina Moshous; Stéphane Blanche; Arnaud Dujardin; Hergen Spits; Jörg H W Distler; Andreas Ramming; Capucine Picard; Rachel Golub; Alain Fischer; Eric Vivier
Journal:  Nat Immunol       Date:  2016-09-12       Impact factor: 25.606

6.  JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.

Authors:  Gina A Montealegre Sanchez; Adam Reinhardt; Suzanne Ramsey; Helmut Wittkowski; Philip J Hashkes; Yackov Berkun; Susanne Schalm; Sara Murias; Jason A Dare; Diane Brown; Deborah L Stone; Ling Gao; Thomas Klausmeier; Dirk Foell; Adriana A de Jesus; Dawn C Chapelle; Hanna Kim; Samantha Dill; Robert A Colbert; Laura Failla; Bahar Kost; Michelle O'Brien; James C Reynolds; Les R Folio; Katherine R Calvo; Scott M Paul; Nargues Weir; Alessandra Brofferio; Ariane Soldatos; Angelique Biancotto; Edward W Cowen; John J Digiovanna; Massimo Gadina; Andrew J Lipton; Colleen Hadigan; Steven M Holland; Joseph Fontana; Ahmad S Alawad; Rebecca J Brown; Kristina I Rother; Theo Heller; Kristina M Brooks; Parag Kumar; Stephen R Brooks; Meryl Waldman; Harsharan K Singh; Volker Nickeleit; Maria Silk; Apurva Prakash; Jonathan M Janes; Seza Ozen; Paul G Wakim; Paul A Brogan; William L Macias; Raphaela Goldbach-Mansky
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

7.  NK cell defects in X-linked pigmentary reticulate disorder.

Authors:  Petro Starokadomskyy; Katelynn M Wilton; Konrad Krzewski; Adam Lopez; Luis Sifuentes-Dominguez; Brittany Overlee; Qing Chen; Ann Ray; Aleksandra Gil-Krzewska; Mary Peterson; Lisa N Kinch; Luis Rohena; Eyal Grunebaum; Andrew R Zinn; Nick V Grishin; Daniel D Billadeau; Ezra Burstein
Journal:  JCI Insight       Date:  2019-11-01
  7 in total
  2 in total

Review 1.  Immune Dysfunction in Mendelian Disorders of POLA1 Deficiency.

Authors:  Petro Starokadomskyy; Andrea Escala Perez-Reyes; Ezra Burstein
Journal:  J Clin Immunol       Date:  2021-01-03       Impact factor: 8.542

Review 2.  Emerging Place of JAK Inhibitors in the Treatment of Inborn Errors of Immunity.

Authors:  Jérôme Hadjadj; Marie-Louise Frémond; Bénédicte Neven
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.